Arrowpoint Investment Partners »

Cg Oncology shares owned by Arrowpoint Investment Partners

Quarter-by-quarter ownership of Cg Oncology (CGON) shares owned by Arrowpoint Investment Partners from 13F filings

Historical chart of Arrowpoint Investment Partners investment in Cg Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cg Oncology held by Arrowpoint Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cg Oncology by Arrowpoint Investment Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $228k 3.4k 67.68

More positions owned by Arrowpoint Investment Partners

Ishares Tr Expanded Tech Call Option (IGV)
Kraneshares Trust Csi Chi Internet (KWEB)
Alphabet Cap Stk Cl A (GOOGL)
Vaneck Etf Trust Semiconductr Etf Put Option (SMH)
Ishares Msci Brazil Etf Call Option (EWZ)
Ase Technology Hldg Sponsored Ads (ASX)
Ionis Pharmaceuticals (IONS)
Neurocrine Biosciences (NBIX)
Axsome Therapeutics (AXSM)
BioMarin Pharmaceutical (BMRN)
Ascendis Pharma A/s Sponsored Adr (ASND)
Ptc Therapeutics I (PTCT)
Pfizer (PFE)
Regeneron Pharmaceuticals (REGN)
Johnson & Johnson (JNJ)

View all positions for Arrowpoint Investment Partners

Top funds holding Cg Oncology

Rtw Investments
Vanguard Group
Decheng Capital
Wellington Management Company
BlackRock
FMR
TCG Crossover Management
Vanguard Portfolio Management
Vanguard Capital Management
Caption Management
State Street Corporation
Foresite Capital Management VI
Geode Capital Management
Franklin Resources
Bank of America Corporation

View all funds holding Cg Oncology